Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial.

Kim SJ, Lo WR, Hubbard GB 3rd, Srivastava SK, Denny JP, Martin DF, Yan J, Bergstrom CS, Cribbs BE, Schwent BJ, Aaberg TM Sr.

Arch Ophthalmol. 2008 Sep;126(9):1203-8. doi: 10.1001/archopht.126.9.1203.

PMID:
18779478
2.
4.

Intraoperative ketorolac and eye pain after viteoretinal surgery: a prospective, randomized, placebo-controlled study.

Fekrat S, Marsh MJ, Elsing SH, Raja SC, de Juan E Jr, Campochiaro PA, Haller JA.

Retina. 2003 Feb;23(1):8-13.

PMID:
12652225
5.
6.

A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.

Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M; Acular LS for Cystoid Macular Edema (ACME) Study Group..

Am J Ophthalmol. 2008 Oct;146(4):554-560. doi: 10.1016/j.ajo.2008.04.036.

PMID:
18599019
7.

Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.

Hirneiss C, Neubauer AS, Kampik A, Schönfeld CL.

Graefes Arch Clin Exp Ophthalmol. 2005 Aug;243(8):768-73.

PMID:
15756571
8.

Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.

Ticly FG, Lira RP, Zanetti FR, Machado MC, Rodrigues GB, Arieta CE.

J Ocul Pharmacol Ther. 2014 Aug;30(6):495-501. doi: 10.1089/jop.2013.0214.

PMID:
24735005
9.

Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy.

Schoenberger SD, Kim SJ, Shah R, Sheng J, Cherney E.

JAMA Ophthalmol. 2014 Jan;132(1):32-7. doi: 10.1001/jamaophthalmol.2013.6203.

PMID:
24336915
10.

Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.

Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A.

Ophthalmology. 2001 Feb;108(2):331-7.

PMID:
11158809
11.

Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery.

Naithani P, Puranik S, Vashisht N, Khanduja S, Kumar S, Garg S.

Retina. 2012 Feb;32(2):250-5. doi: 10.1097/IAE.0b013e31821e2057.

PMID:
21926942
12.

Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.

Heier JS, Topping TM, Baumann W, Dirks MS, Chern S.

Ophthalmology. 2000 Nov;107(11):2034-8;discussion 2039.

PMID:
11054327
13.
14.

Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.

Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T.

J Cataract Refract Surg. 2006 Sep;32(9):1474-82.

PMID:
16931258
15.

Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial.

Zanetti FR, Fulco EA, Chaves FR, da Costa Pinto AP, Arieta CE, Lira RP.

Indian J Ophthalmol. 2012 Jul;60(4):277-81. doi: 10.4103/0301-4738.98705.

16.

Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.

Lindstrom R, Holland E, Lane S, Raizman M, Reilly C.

Cornea. 2008 Apr;27(3):385-6; author reply 386-7. doi: 10.1097/ICO.0b013e31815e7f36. No abstract available.

PMID:
18362679
17.

Reduction of vitreous prostaglandin E2 levels after topical administration of ketorolac 0.45%.

Schoenberger SD, Kim SJ, Sheng J, Calcutt MW.

JAMA Ophthalmol. 2014 Feb;132(2):150-4. doi: 10.1001/jamaophthalmol.2013.5692.

PMID:
24264034
18.

Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.

Toyos R.

Cornea. 2008 Apr;27(3):384; author reply 384-5. doi: 10.1097/ICO.0b013e31815ca67c. No abstract available.

PMID:
18362678
19.

Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.

Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, El-Defrawy SR.

J Cataract Refract Surg. 2012 Sep;38(9):1537-43. doi: 10.1016/j.jcrs.2012.04.034.

PMID:
22795976
20.

Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.

Brint SF, Cheetham JK, DeGryse R, Abel ML, Thompson VM, Rosenthal A.

J Cataract Refract Surg. 1999 Jan;25(1):41-9.

PMID:
9888075
Items per page

Supplemental Content

Support Center